Jill Furman

Jill Furman, JD, is director, Office of Compliance, CDER, at FDA.

Articles by Jill Furman

FDA drug approval process, pharmaceutical regulatory compliance, food and drug administration certification, medical product approval concept, drug testing and approval | image credit: © Сергей Шиманович - © Сергей Шиманович - stock.adobe.com

CBER, CDER Compliance Leaders Outline 2026 Guidance Shifts and Rising GMP Violations

ByFeliza Mirasol,Vince Amatrudo,Jill Furman

September 17th 2026

FDA compliance officers detailed 2026 guidance updates, online drug sale enforcement, and a first-of-its-kind AI-related warning letter at the PDA/FDA Joint Regulatory Conference.

Jill Furman

Articles by Jill Furman

CBER, CDER Compliance Leaders Outline 2026 Guidance Shifts and Rising GMP Violations

Latest Updated Articles